A Phase III, Partially Blind, Randomized Study to Evaluate the Immunogenicity, Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Tritanrix™-HepB and GSK Biologicals Kft's DTPw-HBV Vaccines as Compared to Concomitant Administration of Commonwealth Serum Laboratory's (CSL's) DTPw (Triple Antigen™) and GSK Biologicals' HBV (Engerix™-B), When Co-administered With GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine, to Healthy Infants at 3, 4½ and 6 Months of Age, After a Birth Dose of Hepatitis B Vaccine.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT00158756

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:36:54.764594+00:00

Published At

2017-07-12T00:00:00+00:00

Record Updated At

2018-06-06

Results Posted At

2017-07-12

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Hepatitis B"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2018-06-06"

protocolSection.identificationModule.nctId

"NCT00158756"

protocolSection.identificationModule.officialTitle

"A Phase III, Partially Blind, Randomized Study to Evaluate the Immunogenicity, Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals\u0027 Tritanrix\u2122-HepB and GSK Biologicals Kft\u0027s DTPw-HBV Vaccines as Compared to Concomitant Administration of Commonwealth Serum Laboratory\u0027s (CSL\u0027s) DTPw (Triple Antigen\u2122) and GSK Biologicals\u0027 HBV (Engerix\u2122-B), When Co-administered With GSK Biologicals\u0027 Oral Live Attenuated Human Rotavirus (HRV) Vaccine, to Healthy Infants at 3, 4\u00bd and 6 Months of Age, After a Birth Dose of Hepatitis B Vaccine."

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2017-07-12"

Study condition terms

• Hepatitis B (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.